Jove
Visualize
Contact Us

Related Experiment Videos

Regulatory changes that affect coding for immunotherapy.

J Spencer Atwater1

  • 1Department of Family Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA. Sneeze@aol.com

Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|February 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Access to allergy care: implications for quality healthcare and public safety.

Managed care quarterly·2003
Same author

Allergen immunotherapy.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2003
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Federal regulations have significantly impacted allergy immunotherapy reimbursement and Current Procedural Terminology (CPT) code usage. Allergists must adapt practices to comply with new billing rules and ensure accurate coding for services.

Area of Science:

  • Allergy and Immunology
  • Healthcare Policy
  • Medical Billing and Coding

Background:

  • Federal regulations have increasingly influenced allergen immunotherapy reimbursement and Current Procedural Terminology (CPT) code utilization.
  • The Centers for Medicare and Medicaid Services (CMS), via the Office of the Inspector General (OIG), scrutinized immunotherapy codes due to high usage.
  • Government initiatives aim to enhance compliance and penalize healthcare providers for improper billing practices.

Purpose of the Study:

  • To analyze the impact of federal regulations on reimbursement for allergy immunotherapy and related services.
  • To assess allergists' adherence to new billing rules and coding guidelines.

Main Methods:

  • Review of Office of Inspector General (OIG) survey data on allergy immunotherapy.

Related Experiment Videos

  • Analysis of OIG recommendations regarding Current Procedural Terminology (CPT) coding compliance.
  • Audit of medical records and billing data for 301 physicians using CPT code 95165.

    • Main Results:

    • A preliminary survey indicated issues with the medical appropriateness of allergen immunotherapy.
    • Only 44% of physicians correctly followed the updated definition of a billable dose for code 95165.
    • Significant improper payments were recouped by Medicare, and numerous providers were excluded for fraudulent billing.

    Conclusions:

    • Federal regulations have substantially altered reimbursement landscapes for allergy immunotherapy.
    • Allergists must stay informed about regulatory changes and integrate new coding recommendations into their practice management.
    • Compliance with updated billing rules is crucial for accurate reimbursement and avoiding penalties.